GE HealthCare and RadNet are extending their partnership globally to offer AI-enhanced mammography systems.
Key Details
- 1GE HealthCare and RadNet first partnered in early 2024 to integrate RadNet’s DeepHealth AI breast cancer screening into GEHC mammography devices.
- 2The next phase will see this combined offering distributed internationally, beyond the initial U.S. launch.
- 3The collaboration will now include new AI tools for lesion localization, breast density assessment, and a safeguard review workflow to flag complex cases.
- 4GE HealthCare's platform features a cloud-based multimodality viewer and other workflow enhancements.
- 5RadNet operates over 400 outpatient imaging centers in 10 U.S. states.
Why It Matters
This expansion signifies increased access to advanced, AI-powered breast imaging services for providers worldwide, aiming to facilitate earlier cancer detection and tailored care strategies. The move underscores a growing trend of integrating sophisticated AI into mainstream radiology hardware across global markets.
Source
Radiology Business
Related News
•AuntMinnie
AI Advances in Breast Cancer Risk, CEUS Training Updates, and Imaging AI Variability
This week's top radiology news reviews AI advances in breast and lung cancer risk prediction, new CEUS training standards, and prostate screening updates with imaging modalities.
•Radiology Business
DeepHealth's Prostate AI Gains FDA Clearance for MRI Workflows
DeepHealth, a RadNet subsidiary, received FDA clearance for its AI solution to assist prostate cancer detection and MRI workflow.
•AuntMinnie
Human-AI Collaboration Achieves 99.2% Sensitivity for PE Detection in CTPA
A large study confirms that combining radiologists with FDA-cleared AI significantly improves pulmonary embolism detection on CTPA.